Chemotherapy, irradiation and their roles in the management of oesophageal cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 8, 1997, Pages 612-619

  Blazeby, Jane M ^a   Alderson, Derek ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adjuvant; Chemotherapy; Neoadjuvant; Oesophageal neoplasms; Palliation; Radiotherapy

Indexed keywords

ALCOHOL; BLEOMYCIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOGUAZONE; MITOMYCIN C; VINCRISTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURGICAL MORTALITY; TUMOR VASCULARIZATION; ESOPHAGUS TUMOR; PALLIATIVE THERAPY;

COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; PALLIATIVE CARE;

EID: 0031204036     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00494.x     Document Type: Review

References (72)

1. Office of Population Censuses and Surveys. Mortality Statistics Cause, 1981-1990. London: HMSO, 1991.
2. Parkin DM, Laara E, Muir CS. Estimates of the world-wide frequency of sixteen major cancers in 1980. Int. J. Cancer 1988; 41: 184-97.
3. Yang PC, Davis S. Incidence of cancer of the oesophagus in the US by histologic type. Cancer 1988; 61: 612-17.
4. Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increasing frequency of adenocarcinoma of the oesophagus. Cancer 1989; 64: 526-30.
5. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. JAMA 1991; 265: 1287-9.
6. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br. J. Surg. 1990; 77: 845-57.
7. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br. J. Surg. 1994; 81: 410-13.
8. Baba M, Aikou T, Yoshinaka H et al. Long term results of subtotal oesophagectomy with three field lymphadenectomy for carcinoma of the thoracic oesophagus. Ann. Surg. 1994; 219: 310-16.
9. Watson A. Operable oesophageal cancer: current results from the West. World J. Surg. 1994; 18: 361-6.
10. Kato H, Tachimori Y, Mizobuchi S, Igaki H, Ochiai A. Cervical, mediastinal and abdominal lymph node dissection (three field dissection) for superficial carcinoma of the thoracic oesophagus. Cancer 1993; 72: 2879-82.
11. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic oesophagus. Ann. Surg. 1994; 220: 364-72.
12. Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR. Multimodality treatment for squamous cell oesophageal cancer World J. Surg. 1995; 19: 198-204.
13. Kato H, Watanabe H, Tachimori Y, Iizuka T. Evaluation of neck lymph node dissection for thoracic oesophageal carcinoma. Ann. Thorac. Surg. 1991; 51: 931-5.
14. Kelsen DP. Preoperative chemotherapy in oesophageal carcinoma. World. J. Surg. 1987; 11: 433-8.
15. Walker SJ, Allen SM, Steel A, Cullen MH, Matthews HR. Assessment of the response to chemotherapy in oesophageal cancer. Eur. J. Cardiothorac. Surg. 1991; 5: 519-22.
16. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumour removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 1983; 43: 1488-92.
17. Goldie JH, Coldman AJ. Genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res. 1984; 44: 3643-53.
18. Coia LR, Soffen EM, Schultheiss TE, Martin EE, Hanks GE. Swallowing function in patients with oesophageal cancer treated with concurrent radiation and chemotherapy. Cancer 1993; 71: 281-6.
19. Lui GS, Huang ZF, Rong TH, Yang MT, Chang EP, Xiao QX. Measures for improving therapeutic results of oesophageal carcinoma in stage III: Preoperative radio-therapy. J. Surg. Oncol. 1986; 32: 248-55.
20. Diehl LF. Radiation and chemotherapy in the treatment of oesophageal cancer. Gastroenterol. Clin. North Am. 1991; 20: 765-74.
21. Sugimachi K, Matsufuji H, Kai H et al. Preoperative irradiation for carcinoma of the oesophagus. Surg. Gynecol. Obstet. 1986; 162: 174-6.
22. Arnott SJ, Duncan W, Kerr GR et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomised clinical trial. Radiother. Oncol. 1992; 24: 108-13.
23. Huang GJ, Wang LJ, Liu JS et al. Surgery of oesophageal carcinoma. Semin. Surg. Oncol. 1985; 1: 74-83.
24. Wang M, Gu XZ, Yin W, Huang GJ, Wang LJ, Zhang DW. Randomised clinical trial on the combination of preoperative irradiation and surgery in the treatment of oesophageal carcinoma: report on 206 patients. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 325-7.
25. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the oesophagus. Surg. Gynecol. Obstet. 1981; 153: 690-2.
26. Gignoux M, Roussel A, Paillot B et al. The value of preoperative radiotherapy in oesophageal cancer: results of a study of the EORTC. World. J. Surg. 1987; 11: 426-32.
27. Nygaard K, Hagen S, Hansen HS et al. Preoperative radiotherapy prolongs survival in operable oesophageal carcinoma: a randomised, multicentre study of preoperative radiotherapy and chemotherapy: the second Scandinavian trial in oesophageal cancer. World. J. Surg. 1992; 16: 1104-10.
28. Gill PG, Jamieson GG, Denham J et al. Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapy. Br. J. Surg. 1990; 77: 1020-3.
29. Forastiere AA, Gennis M, Orringer MB, Agha FP. Cisplatin, vinblastine and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the oesophagus. J. Clin. Oncology 1987; 5: 1143-9.
30. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomised clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine and bleomycin for carcinoma of the oesophagus. J. Thorac. Cardiovasc. Surg. 1988; 96: 242-8.
31. Schlag PM. Randomised trial of preoperative chemotherapy for squamous cell cancer of the oesophagus. Arch. Surg. 1992; 127: 1446-50.
32. Kelsen DP, Minsky B, Smith M et al. Preoperative therapy for oesophageal cancer: a randomised comparison of chemotherapy versus radiation therapy. J. Clin. Oncology 1990; 8: 1352-61.
33. Girling DJ. British Medical Research Council protocol OE02: Randomised controlled clinical trial of surgery with or without preoperative chemotherapy in the treatment of resectable cancer of the oesophagus. Cambridge: Cancer Trials Office, 1993.
34. Bessell JR, Devitt PG, Gill PG, Goyal GS, Jamieson GG. Prolonged survival follows resection of oesophageal SCC downstaged by prior chemoradiotherapy, Aust. N.Z. J. Surg. 1996; 66: 214-7.
35. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumour regression after preoperative chemoradiotherapy of oesophageal carcinoma. Cancer 1994; 73: 2680-6.
36. Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER. Downstaging of oesophageal cancer after preoperative radiation and chemotherapy. Ann. Surg. 1995; 221: 685-95.
37. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Concurrent chemotherapy and radiation therapy followed by transhiatal oesophagectomy for local-regional cancer of the oesophagus. J. Clin. Oncology 1990; 8: 119-27.
38. Stewart JR, Hoff SJ, Johnson DH et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the oesophagus. Ann. Surg. 1993; 218: 571-8.
39. Poplin E, Fleming T, Leichman LP et al. Combined therapies for squamous cell carcinoma of the oesophagus, a Southwest Oncology Group Study (SWOG-8037). J. Clin. Oncology 1987; 5: 622-8.
40. Le Prise E, Etienne PL, Meunier B et al. A randomised study of chemotherapy, radiation therapy, and surgery versus surgery for localised squamous cell carcinoma of the oesophagus. Cancer 1994; 73: 1779-84.
41. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodality therapy and surgery for oesophageal adenocarcinoma. N. Engl. J. Med. 1996; 335: 462-7.
42. Wilke H, Fink U. Multimodality therapy for adenocarcinoma of the oesophagus and oesophagogastric junction. N. Engl. J. Med. 1996; 335: 509-10.
43. Iizuka T, Ide H, Kakegawa T et al. Preoperative radiotherapy for oesophageal carcinoma - randomised evaluation trial in eight institutions. Chest 1988; 93: 1054-8.
44. Fok M, Sham JST, Choy D, Cheng SWK, Wong J. Postoperative radiotherapy for carcinoma of the oesophagus: a prospective randomised controlled trial. Surgery 1993; 113: 138-47.
45. Teniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower oesophagus as shown by a multicentre controlled trial. Surg. Gynecol. Obstet. 1991; 173: 123-30.
46. Japanese Oesophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for oesophageal carcinoma. Chest 1993; 104: 203-7.
47. Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB. Chemotherapy for carcinoma of the oesophagus: a comparison of evidence from meta-analyses of randomised trials and of historical control studies. Ann. Oncol. 1996; 7: 355-9.
48. Nishihira T, Nakano T, Mori S. Adjuvant therapies for cancer of the thoracic oesophagus. World J Surg 1994; 18: 388-98.
49. Coia LR. Chemoradiation as primary management of oesophageal cancer. Semin. Oncol. 1994; 21: 483-92.
50. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. N. Engl. J. Med. 1992; 326: 1593-8.
51. O'Reilly S, Forastiere AA. Is surgery necessary with multimodality treatment of oesophageal cancer. Ann. Oncol. 1995; 6: 519-21.
52. Leichman L, Herskovic A, Leichman CG et al. Non operative therapy for squamous cell cancer of the oesophagus. J. Clin. Oncology 1987; 5: 365-70.
53. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long term results of infusional 5-FU, mitomycin-C and radiation as primary management of oesophageal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1991; 20: 29-36.
54. John MJ, Flam MS, Mowry PA et al. Radiotherapy alone and chemoradiation for nonmetastatic oesophageal carcinoma: a critical review of chemoradiation. Cancer 1989; 63: 2397-403.
55. Roussel A, Jacob JH, Haegele P et al. Controlled clinical trial for the treatment of patients with inoperable oesophageal carcinoma: A study of the EORTC gastrointestinal tract cancer cooperative group. Recent Results Cancer Res. 1988; 110: 21-9.
56. Earle JD, Gelber RD, Moertel CG, Hahn RG. A controlled evaluation of combined radiotherapy and bleomycin therapy for squamous cell carcinoma of the oesophagus. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6: 821-6.
57. Araujo CMM, Souhami L, Gil RA et al. A randomised trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic oesophagus. Cancer 1991; 67: 2258-61.
58. Pearson JG. The radiotherapy of carcinoma of the oesophagus and post cricoid region in South East Scotland. Clin. Radial. 1966; 17: 242-57.
59. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: II. A critical view of radiotherapy. Br. J. Surg. 1980; 67: 457-61.
60. Earlam RJ, Johnson L. 101 oesophageal cancers: a surgeon uses radiotherapy. Ann. R. Coll. Surg. Engl. 1990; 72: 32-40.
61. De-Ren S. Ten-year follow up of oesophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 329-34.
62. Wara WM, Mauch PM, Thomas AN, Phillips TL. Palliation for carcinoma of the oesophagus. Ther. Radiology 1976; 121: 717-20.
63. Rowland CG, Pagliero KM. Intracavitary radiation in palliation of carcinoma of oesophagus and cardia. Lancet 1985; ii: 981-2.
64. Bader M, Dittler HJ, Ultsch B, Ries G, Siewert JR. Palliative treatment of malignant stenoses of the upper gastrointestinal tract using a combination of laser and after loading therapy. Endoscopy 1986; 18 (Suppl. 1): 27-31.
65. Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T. High-dose-rate intraluminal brachytherapy for oesophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother. Oncol. 1991; 21: 107-14.
66. Hishikawa Y, Tanaka S, Miura T. Oesophageal ulceration induced by intracavitary irradiation for oesophageal carcinoma. Am. J. Radial. 1984; 143: 269-73.
67. Bamias A, Hill ME, Cunningham D et al. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for oesophagogastric adenocarcinoma. Cancer 1996; 77: 1978-85.
68. Highley MS, Parnis FX, Trotter GA et al. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. Br. J. Surg. 1994; 81: 1763-5.
69. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br. J. Cancer 1995; 71: 587-91.
70. Murad AM, Santiago FF, Petroianu A, Rocha PRS, Rodrigues MAG, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41.
71. Izquierdo MA, Marcuello E, de Segura GG et al. Unresectable non-metastatic squamous cell carcinoma of the oesophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy. Cancer 1993; 71: 287-92.
72. Stewart FM, Harkins BJ, Hahn SS, Daniel TM. Cisplatin, 5-fluorouracil, mitomycin C and concurrent radiation therapy with and without oesophagectomy for oesophageal carcinoma. Cancer 1989; 64: 622-8.